Mother and son jogging Mother and son jogging Mother and son jogging Mother and son jogging
News Releases

News Releases

Date Title and Summary
Toggle Summary Abbott Hosts Conference Call for Third-Quarter Earnings
ABBOTT PARK, Ill., Sept. 19, 2018 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2018 financial results on Wednesday, Oct. 17, 2018 , before the market opens.  The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time ( 9 a.m.
Toggle Summary Abbott Declares 379th Consecutive Quarterly Dividend
ABBOTT PARK, Ill., Sept. 13, 2018 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 28 cents per share. This marks the 379 th consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is payable Nov.
Toggle Summary Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)
- Company achieves more than double the overall average industry score and maintains top industry scores in economic and social performance - Abbott recognized for sustainability on DJSI for 14 consecutive years ABBOTT PARK, Ill., Sept. 13, 2018 /PRNewswire/ -- For the sixth consecutive year,
Toggle Summary New Coverage Decision Extends Abbott's Innovative Pain Therapy Option to 22 Million Americans Living with Chronic Pain
- Aetna, one of the leading health care benefits companies in the United States, now covers an additional Abbott neurostimulation technology with a new national coverage policy - Abbott is the only company in the world with FDA and CE Mark approval to offer dorsal root ganglion (DRG)
Toggle Summary Abbott Expands its Directional Deep Brain Stimulation Therapy by Offering New MR-Conditional Labeling
- FDA approval of new software upgrade for Abbott's deep brain stimulation therapy enables advanced, patient-centric features for people living with Parkinson's disease and essential tremor - New Informity™ tool helps simplify the Infinity™ DBS system programming process for physicians ABBOTT PARK,
Toggle Summary Abbott's FreeStyle® Libre 14 Day Flash Glucose Monitoring System Now Approved in U.S.
- ALLOWS USERS TO WEAR THE SENSOR FOR UP TO 14 DAYS WITH HIGH ACCURACY - FREESTYLE LIBRE 14 DAY NOW THE LONGEST-LASTING SELF-APPLIED CONTINUOUS GLUCOSE SENSING TECHNOLOGY AVAILABLE - FREESTYLE LIBRE SYSTEM NOW BEING USED BY MORE THAN 800,000 PEOPLE WITH DIABETES GLOBALLY AND IS THE WORLD'S #1 CGM
Toggle Summary Abbott Begins U.S. Pivotal Trial for the Tendyne Mitral Valve Replacement System to Treat Patients with Heart Valve Disease
- Investigational Tendyne device is first and only repositionable and fully retrievable mitral valve replacement - Valve is designed to allow doctors to replace damaged mitral heart valves without open-heart surgery - Early results from separate global study are promising ABBOTT PARK, Ill., July
Toggle Summary Abbott Reports Second-Quarter 2018 Results
- Second-quarter reported sales growth of 17.0 percent; GAAP EPS from continuing operations of $0.40 - Second-quarter organic sales growth of 8.0 percent - Second-quarter adjusted EPS from continuing operations of $0.73, above previous guidance range - Raises full-year 2018 outlook ABBOTT PARK,
Toggle Summary Abbott Receives FDA Approval for Next-Generation MitraClip® Device to Treat People with Leaky Heart Valves
- Innovations designed to allow doctors to treat more types of cases and anatomies - MitraClip is the gold-standard minimally invasive alternative to open-heart surgery for people needing mitral valve repair - Mitral regurgitation, the most common heart valve disease, affects one in 10 adults over
Toggle Summary Abbott Announces Freedom 2 Save Program for Employees to Address Student Debt
- Two-Thirds of Millennials Aren't Saving for Retirement - Benefit Means Student Debt Won't Prevent Retirement Savings ABBOTT PARK, Ill., June 26, 2018 /PRNewswire/ -- Historic levels of student debt have forced many people to choose between saving for their futures and paying off school loans.